The efficacy of bisphosphonate in controlling skeletally-related event in cancer patients without a great number of adverse events has resulted in a widespread use of these medications in oncology. Zoledronic acid and pamidronate are the most common bisphosphonates intravenously administered as a preventive treatment of bone complications encountered in multiple myeloma, as well as a palliative treatment of bone metastases in a large variety of solid tumours including breast, prostate and lung cancers. However, in recent years a relationship has been established between these drugs and a new bone injury characterised by avascular necrosis of bone that was isolated to the jaws. This paper reviews the literature concerning the discovery of this disease, its clinical, radiological and histological manifestations; its pathogenesis, with a look at the treatment and future options in preventing this complication and in treating hypercalcemia and bone lytic lesions in solid tumours.

Raffaelli, L., Scaramuzzo, L., Rossi Iommetti, P., Graci, C., Maccauro, G., Manicone, P. F., Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis, <<JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS>>, 2010; 24 (2): 115-121 [http://hdl.handle.net/10807/28672]

Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis

Raffaelli, Luca;Scaramuzzo, Laura;Rossi Iommetti, Pierfrancesco;Graci, Calogero;Maccauro, Giulio;Manicone, Paolo Francesco
2010

Abstract

The efficacy of bisphosphonate in controlling skeletally-related event in cancer patients without a great number of adverse events has resulted in a widespread use of these medications in oncology. Zoledronic acid and pamidronate are the most common bisphosphonates intravenously administered as a preventive treatment of bone complications encountered in multiple myeloma, as well as a palliative treatment of bone metastases in a large variety of solid tumours including breast, prostate and lung cancers. However, in recent years a relationship has been established between these drugs and a new bone injury characterised by avascular necrosis of bone that was isolated to the jaws. This paper reviews the literature concerning the discovery of this disease, its clinical, radiological and histological manifestations; its pathogenesis, with a look at the treatment and future options in preventing this complication and in treating hypercalcemia and bone lytic lesions in solid tumours.
Inglese
Raffaelli, L., Scaramuzzo, L., Rossi Iommetti, P., Graci, C., Maccauro, G., Manicone, P. F., Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis, <>, 2010; 24 (2): 115-121 [http://hdl.handle.net/10807/28672]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/28672
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact